Overview
My current research focuses on investigating B and T cell population differences in chronic lymphocytic leukaemia (CLL) mouse models before and after Bruton Tyrosine Kinase (BTK) inhibitor treatments.
Related News
Blood Cancer Awareness Month: how can we personalise treatments to improve care?
For Blood Cancer Awareness Month, Dr Lou Herman reflects on the current challenges facing blood cancer patients and how we’re addressing them.
Interviews 30 September 2024